Opus Genetics (IRD) Other Working Capital Changes (2010 - 2026)
Opus Genetics (IRD) reported Other Working Capital Changes of $2.1 million for Q1 2026, up 147.28% year-over-year from $865000.0 in Q1 2025, and up 119.84% on a QoQ basis from $973000.0 in Q4 2025.
Opus Genetics (IRD) has 17 years of Other Working Capital Changes data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 147.28% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 1207.39% YoY) and the FY2025 annual result came in at $1.3 million, up 300.79% from the prior year.
- Other Working Capital Changes rose to $2.1 million in Q1 2026 per IRD's latest filing, from $973000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.1 million in Q1 2026 and bottomed at -$685000.0 in Q3 2024.
- The 5-year median for Other Working Capital Changes is $82.0 (2022), against an average of $171651.9.
- The widest annual swing landed in 2023, when Other Working Capital Changes sank 434246.34%; it then surged 2602.78% in 2025.
- Tracing IRD's Other Working Capital Changes over 5 years: stood at $848000.0 in 2022, then dropped by 27.48% to $615000.0 in 2023, then sank by 94.15% to $36000.0 in 2024, then surged by 2602.78% to $973000.0 in 2025, then surged by 119.84% to $2.1 million in 2026.
- Per Business Quant, the three latest IRD Other Working Capital Changes figures stand at $2.1 million (Q1 2026), $973000.0 (Q4 2025), and -$618000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 973,000.00 |
| Dec 31, 2025 | 973,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Mar 31, 2024 | 461,000.00 |
| Mar 31, 2024 | 461,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -356,000.00 |
| Jun 30, 2023 | -356,000.00 |
| Mar 31, 2023 | -365,000.00 |
| Mar 31, 2023 | -365,000.00 |
| Dec 31, 2022 | 848,000.00 |
| Dec 31, 2022 | 848,000.00 |
| Sep 30, 2022 | -135,000.00 |
| Sep 30, 2022 | -135,000.00 |
| Jun 30, 2022 | 82.00 |
| Jun 30, 2022 | 82.00 |
| Mar 31, 2022 | -219,000.00 |
| Mar 31, 2022 | -219,000.00 |
| Dec 31, 2021 | 754,000.00 |
| Dec 31, 2021 | 754,000.00 |
| Sep 30, 2021 | 41.00 |
| Sep 30, 2021 | 41.00 |
| Jun 30, 2021 | 41.00 |
| Jun 30, 2021 | 41.00 |
| Mar 31, 2021 | 159,000.00 |
| Mar 31, 2021 | 159,000.00 |
| Dec 31, 2020 | 1.03 Mn |
| Dec 31, 2020 | 1.03 Mn |
| Sep 30, 2020 | 3,162.00 |
| Sep 30, 2020 | 3,162.00 |
| Jun 30, 2020 | 2,996.00 |
| Jun 30, 2020 | 2,996.00 |
| Mar 31, 2020 | 2,498.00 |
| Mar 31, 2020 | 2,498.00 |
| Dec 31, 2019 | 275,132.00 |
| Dec 31, 2019 | 275,132.00 |
| Sep 30, 2019 | 2,080.00 |
| Sep 30, 2019 | 2,080.00 |
| Jun 30, 2019 | 2,080.00 |
| Jun 30, 2019 | 2,080.00 |
| Mar 31, 2019 | 1,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | -81,051.00 |
| Dec 31, 2018 | -81,051.00 |
| Sep 30, 2018 | 25,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 10,000.00 |
| Jun 30, 2018 | 10,000.00 |
| Mar 31, 2018 | -73,276.00 |
| Mar 31, 2018 | -73,276.00 |
| Dec 31, 2017 | 26,937.00 |
| Dec 31, 2017 | 26,937.00 |
| Sep 30, 2017 | 15,000.00 |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | 15,000.00 |
| Jun 30, 2017 | 15,000.00 |
| Mar 31, 2017 | 356,608.00 |
| Mar 31, 2017 | 356,608.00 |
| Dec 31, 2016 | -193,536.00 |
| Dec 31, 2016 | -193,536.00 |
| Sep 30, 2016 | 610,000.00 |
| Sep 30, 2016 | 610,000.00 |
| Jun 30, 2016 | 610,000.00 |
| Jun 30, 2016 | 610,000.00 |
| Mar 31, 2016 | -275,757.00 |
| Mar 31, 2016 | -275,757.00 |
| Dec 31, 2015 | -253,939.00 |
| Dec 31, 2015 | -253,939.00 |
| Sep 30, 2015 | 1.74 Mn |
| Sep 30, 2015 | 1.74 Mn |
| Jun 30, 2015 | 1.43 Mn |
| Jun 30, 2015 | 1.43 Mn |
| Mar 31, 2015 | 260,040.00 |
| Mar 31, 2015 | 260,040.00 |
| Dec 31, 2014 | -835.00 |
| Dec 31, 2014 | -835.00 |
| Sep 30, 2014 | 35,795.00 |
| Sep 30, 2014 | 35,795.00 |
| Jun 30, 2014 | 175,828.00 |
| Jun 30, 2014 | 175,828.00 |
| Mar 31, 2014 | 218,304.00 |
| Mar 31, 2014 | 218,304.00 |
| Dec 31, 2013 | -15,952.00 |
| Dec 31, 2013 | -15,952.00 |
| Sep 30, 2013 | 225,000.00 |
| Sep 30, 2013 | 225,000.00 |
| Jun 30, 2013 | 207,351.00 |
| Jun 30, 2013 | 207,351.00 |
| Mar 31, 2013 | -5,488.00 |
| Mar 31, 2013 | -5,488.00 |
| Dec 31, 2012 | -29,218.00 |
| Dec 31, 2012 | -29,218.00 |
| Sep 30, 2012 | -115,879.00 |
| Sep 30, 2012 | -115,879.00 |
| Jun 30, 2012 | 46,653.00 |
| Jun 30, 2012 | 46,653.00 |
| Mar 31, 2012 | -45,919.00 |
| Mar 31, 2012 | -45,919.00 |
| Dec 31, 2011 | -122,538.00 |
| Dec 31, 2011 | -122,538.00 |
| Sep 30, 2011 | -30,389.00 |
| Sep 30, 2011 | -30,389.00 |
| Jun 30, 2011 | -239,024.00 |
| Jun 30, 2011 | -239,024.00 |
| Mar 31, 2011 | 18,473.00 |
| Mar 31, 2011 | 18,473.00 |
| Dec 31, 2010 | 225,601.00 |
| Dec 31, 2010 | 225,601.00 |
| Sep 30, 2010 | -107,926.00 |
| Sep 30, 2010 | -107,926.00 |